{"data":[{"accessionNo":"0000070858-26-000528","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BANK OF AMERICA CORP /DE/","reportingCik":null,"personType":"HC","sharesOwned":11867012,"percentOfClass":5.4,"filedAt":"2026-10-28","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Kynam Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":9.96,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Yue Tang","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":9.96,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000014","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-06-30","reportingPerson":"Kynam Capital Management, LP","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":9.96,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000919574-26-005484","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":7811033,"percentOfClass":3.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000919574-26-005484","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":7811033,"percentOfClass":3.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000919574-26-005484","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-06-30","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":7811033,"percentOfClass":3.6,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000093751-26-000448","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CYTOMX THERAPEUTICS INC","ticker":"CTMX","cusip":"23284F105","securityClass":"COMMON STOCK","eventDate":"2026-06-30","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":11747236,"percentOfClass":5.4,"filedAt":"2026-08-07","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000070858-26-000395","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BANK OF AMERICA CORP /DE/","reportingCik":null,"personType":"HC","sharesOwned":15134689,"percentOfClass":7,"filedAt":"2026-08-03","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0002012383-26-002247","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CYTOMX THERAPEUTICS, INC","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":16551452,"percentOfClass":7.6,"filedAt":"2026-07-27","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-227057","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Patrick G. Enright","reportingCik":null,"personType":"IN","sharesOwned":15288461,"percentOfClass":7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-227057","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Juliet Tammenoms Bakker","reportingCik":null,"personType":"IN","sharesOwned":15288461,"percentOfClass":7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000010","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Kynam Capital Management, LP","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":6.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000010","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Yue Tang","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":6.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000010","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Kynam Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":6.9,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-227057","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Longitude Venture Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":12458461,"percentOfClass":5.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-227057","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Longitude Capital Partners V, LLC","reportingCik":null,"personType":"OO","sharesOwned":12458461,"percentOfClass":5.7,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":9982124,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":9982124,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":9982124,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":9982124,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":9982124,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":9982124,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-26-000064","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":9982124,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-226556","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Perceptive Life Sciences Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":10098824,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-226556","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Joseph Edelman","reportingCik":null,"personType":"IN","sharesOwned":10098824,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-226556","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Perceptive Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":10098824,"percentOfClass":4.6,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-227057","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Longitude 103.8 East Partners, LLC","reportingCik":null,"personType":"OO","sharesOwned":2830000,"percentOfClass":1.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001193125-26-227057","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2026-03-31","reportingPerson":"Longitude 103.8 East, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2830000,"percentOfClass":1.3,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001013594-26-000617","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share (\"Common Stock\")","eventDate":"2026-03-31","reportingPerson":"Seven Fleet Capital Management LP","reportingCik":null,"personType":"OO","sharesOwned":1085398,"percentOfClass":0.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001013594-26-000617","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share (\"Common Stock\")","eventDate":"2026-03-31","reportingPerson":"Seven Fleet Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":1085398,"percentOfClass":0.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001013594-26-000617","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share (\"Common Stock\")","eventDate":"2026-03-31","reportingPerson":"Brian Liu","reportingCik":null,"personType":"IN","sharesOwned":1085398,"percentOfClass":0.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001013594-26-000617","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, $0.00001 par value per share (\"Common Stock\")","eventDate":"2026-03-31","reportingPerson":"Seven Fleet Capital Management GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1085398,"percentOfClass":0.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000902664-26-002013","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-04-15","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":10864581,"percentOfClass":5,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000902664-26-002013","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-04-15","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":10864581,"percentOfClass":5,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000902664-26-002013","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2026-04-15","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":10864581,"percentOfClass":5,"filedAt":"2026-04-16","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000102909-26-001034","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics Inc","ticker":"CTMX","cusip":"23284F105","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"Kynam Capital Management, LP","reportingCik":null,"personType":"IA","sharesOwned":8966077,"percentOfClass":5.29,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"Kynam Capital Management GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":8966077,"percentOfClass":5.29,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001907884-26-000006","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-12-31","reportingPerson":"Yue Tang","reportingCik":null,"personType":"IN","sharesOwned":8966077,"percentOfClass":5.29,"filedAt":"2026-03-04","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000947871-26-000190","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"OrbiMed Advisors LLC","reportingCik":null,"personType":"IA","sharesOwned":3525650,"percentOfClass":2.1,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001214659-26-002019","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL MANAGEMENT, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001214659-26-002019","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"KEVIN TANG","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001214659-26-002019","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL PARTNERS, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001214659-26-002019","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL PARTNERS INTERNATIONAL, LP","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001214659-26-002019","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL PARTNERS III, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001214659-26-002019","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-12-31","reportingPerson":"TANG CAPITAL PARTNERS IV, INC","reportingCik":null,"personType":"CO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000315066-26-000388","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501989","issuerName":"CYTOMX THERAPEUTICS INC","ticker":"CTMX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":24688109,"percentOfClass":14.6,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000315066-26-000388","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001501989","issuerName":"CYTOMX THERAPEUTICS INC","ticker":"CTMX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":24688109,"percentOfClass":14.6,"filedAt":"2026-02-05","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-25-000016","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Management III, LLC","reportingCik":null,"personType":"OO","sharesOwned":15561500,"percentOfClass":9.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-25-000016","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Co-Investment Holdings III, LLC","reportingCik":null,"personType":"OO","sharesOwned":15561500,"percentOfClass":9.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-25-000016","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Venrock Healthcare Capital Partners EG, L.P.","reportingCik":null,"personType":"PN","sharesOwned":15561500,"percentOfClass":9.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-25-000016","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Bong Y. Koh","reportingCik":null,"personType":"IN","sharesOwned":15561500,"percentOfClass":9.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-25-000016","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Nimish Shah","reportingCik":null,"personType":"IN","sharesOwned":15561500,"percentOfClass":9.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-25-000016","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"VHCP Management EG, LLC","reportingCik":null,"personType":"OO","sharesOwned":15561500,"percentOfClass":9.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001738048-25-000016","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Venrock Healthcare Capital Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":15561500,"percentOfClass":9.4,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000902664-25-005005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4068575,"percentOfClass":2.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000902664-25-005005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":4068575,"percentOfClass":2.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000902664-25-005005","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, par value $0.00001 per share","eventDate":"2025-09-30","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":4068575,"percentOfClass":2.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001013594-25-001422","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Brian Liu","reportingCik":null,"personType":"IN","sharesOwned":48898,"percentOfClass":0.02,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001013594-25-001422","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Seven Fleet Capital Management GP LLC","reportingCik":null,"personType":"OO","sharesOwned":48898,"percentOfClass":0.02,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001013594-25-001422","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Seven Fleet Capital Management LP","reportingCik":null,"personType":"OO","sharesOwned":48898,"percentOfClass":0.02,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0001013594-25-001422","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CytomX Therapeutics, Inc.","ticker":"CTMX","cusip":null,"securityClass":"Common Stock, $0.00001 par value per share","eventDate":"2025-09-30","reportingPerson":"Seven Fleet Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":48898,"percentOfClass":0.02,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000315066-25-002911","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CYTOMX THERAPEUTICS INC","ticker":"CTMX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-10-31","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":20519967,"percentOfClass":12.4,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000315066-25-002911","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001501989","issuerName":"CYTOMX THERAPEUTICS INC","ticker":"CTMX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-10-31","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":20519967,"percentOfClass":12.4,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000315066-25-002714","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CYTOMX THERAPEUTICS INC","ticker":"CTMX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"FMR LLC","reportingCik":null,"personType":"HC","sharesOwned":15396200,"percentOfClass":9.3,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"},{"accessionNo":"0000315066-25-002714","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001501989","issuerName":"CYTOMX THERAPEUTICS INC","ticker":"CTMX","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-09-30","reportingPerson":"Abigail P. Johnson","reportingCik":null,"personType":"IN","sharesOwned":15396200,"percentOfClass":9.3,"filedAt":"2025-11-05","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx"}],"updatedAt":"2026-11-05T13:32:57.507Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/ctmx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}